Publications
Quick Links
Read the Full Issue (Members Only)
Past Free Issues
- Risk and Statistics Serve as Tools for Solving Variation Riddles and Creating Robust Processes
- Will FDA Combo Rule Help Pharma with Quality Systems?
- PDA Metro Chapter Learns the Fine Art of Investigations
- Global Regulators Address Role of Quality in Shortages, Seek Solutions
- Annual Meeting Plenary Talk to Address Shortages
- Tech Trends: Companies Expanding LMS to Include Content
About PDA Letter
The PDA Letter is PDA's membership publication covering the science, technology, quality, regulatory affairs and association news and updates relevant to the PDA community. It publishes 10 times per year, with issues in January, February, March, April, May, June, September and October, as well as two larger issues for July/August and November/December.
The PDA Letter is divided into seven sections, one for each PDA department and a features section. Feature articles are supplied by PDA members, industry and regulatory experts and occasionally by PDA staff. The PDA Letter Editorial Committee (PLEC) provides editorial oversight for all feature articles.
PDA Letter Editorial Committee
- Suzanne Auckerman, Auckerman Consulting
- Vincent Anicetti, Keck Graduate Institute of Applied Life Sciences
- Harold Baseman, ValSource
- John Paul Bevel, Teva Pharma
- Purusottom Bhattacharjee, Fresenius Kabi
- Mitchell Ehrlich, Fresenius-Kabi
- Karen Ginsbury, PCI Pharmaceutical Consulting
- Tricia Griffiths, EMD Millipore
- Mike Long, ValSource
- Rainer Newman
- Peter Noverini, Azbil BioVigilant
- Kathleen O'Sulivan, BD
- Debbie Rogers, Ben Venue Laboratories
- Barbara Sneade, Grifols
- Sarah Thomas, Human Genome Sciences
- Elisa Yee, Hospira
PDA Letter Staff
Walter Morris, Director of Publishing
Tel: (301) 656-5900 x148
E-mail: morris@pda.org
Rebecca Stauffer, Assistant Editor
Tel: (301) 656-5900 x120
E-mail: stauffer@pda.org
Katja Yount, Publication Design Specialist
Tel: (301) 656-5900 x161
E-mail: yount@pda.org